WASHINGTON, Jan. 7, 2019 /PRNewswire/ -- Danaher Corporation
(NYSE: DHR) (the "Company") announced that its President and Chief
Executive Officer, Thomas P. Joyce,
Jr., will comment tomorrow on the Company's fourth quarter
2018 performance in a presentation at the J.P. Morgan Healthcare
Conference in San Francisco,
California at 8:00 a.m. PT.
Mr. Joyce will communicate that fourth quarter 2018 core revenue
growth is expected to be above the Company's previously announced
guidance and adjusted diluted net earnings per share is expected to
be at or near the high-end of the Company's previously announced
guidance.
As previously announced, Danaher will hold its quarterly
earnings conference call for the fourth quarter and year-end 2018
on Tuesday, January 29, 2019 at
8:00 a.m. ET.
ABOUT DANAHER
Danaher is a global science and
technology innovator committed to helping its customers solve
complex challenges and improving quality of life around the world.
Its family of world class brands has leadership positions in some
of the most demanding and attractive industries, including health
care, environmental and industrial. With more than 20 operating
companies, Danaher's globally diverse team of approximately 67,000
associates is united by a common culture and operating system, the
Danaher Business System. For more information, please visit
www.danaher.com
FORWARD LOOKING STATEMENTS
Statements in this release
that are not strictly historical, including the statements
regarding the Company's anticipated financial performance for the
fourth quarter and any other statements regarding events or
developments that we believe or anticipate will or may occur in the
future are "forward-looking" statements within the meaning of the
federal securities laws. There are a number of important
factors that could cause actual results, developments and business
decisions to differ materially from those suggested or indicated by
such forward-looking statements and you should not place undue
reliance on any such forward-looking statements. These
factors include, among other things, Danaher's ability to complete
the previously-announced spin-off of its Dental business on the
currently contemplated timeline and achieve the intended benefits,
deterioration of or instability in the economy, the markets we
serve and the financial markets, developments and uncertainties in
U.S. policy stemming from the current administration, such as
changes in U.S. trade and tariff policies and the reaction of other
countries thereto, contractions or growth rates and cyclicality of
markets we serve, competition, our ability to develop and
successfully market new products and technologies and expand into
new markets, the potential for improper conduct by our employees,
agents or business partners, our compliance with applicable laws
and regulations (including regulations relating to medical devices
and the health care industry), our ability to effectively address
cost reductions and other changes in the health care industry, our
ability to successfully identify and consummate appropriate
acquisitions and strategic investments and successfully complete
divestitures and other dispositions, our ability to integrate the
businesses we acquire and achieve the anticipated benefits of such
acquisitions, contingent liabilities relating to acquisitions,
investments and divestitures (including tax-related and other
contingent liabilities relating to past and future split-offs or
spin-offs), security breaches or other disruptions of our
information technology systems or violations of data privacy laws,
the impact of our restructuring activities on our ability to grow,
risks relating to potential impairment of goodwill and other
intangible assets, currency exchange rates, tax audits and changes
in our tax rate and income tax liabilities, changes in tax laws
applicable to multinational companies, litigation and other
contingent liabilities including intellectual property and
environmental, health and safety matters, the rights of
the United States government to
use, disclose and license certain intellectual property we license
if we fail to commercialize it, risks relating to product, service
or software defects, product liability and recalls, risks relating
to product manufacturing, the impact of our debt obligations on our
operations and liquidity, our relationships with and the
performance of our channel partners, uncertainties relating to
collaboration arrangements with third-parties, commodity costs and
surcharges, our ability to adjust purchases and manufacturing
capacity to reflect market conditions, reliance on sole sources of
supply, the impact of deregulation on demand for our products and
services, labor matters, international economic, political, legal,
compliance and business factors (including the impact of the
United Kingdom's decision to leave
the EU), disruptions relating to man-made and natural disasters,
and pension plan costs. Additional information regarding the
factors that may cause actual results to differ materially from
these forward-looking statements is available in our SEC filings,
including our 2017 Annual Report on Form 10-K and Quarterly Report
on Form 10-Q for the third quarter of 2018. These
forward-looking statements speak only as of the date of this
release and except to the extent required by applicable law, the
Company does not assume any obligation to update or revise any
forward-looking statement, whether as a result of new information,
future events and developments or otherwise.
View original
content:http://www.prnewswire.com/news-releases/danaher-ceo-to-comment-on-financial-performance-300774346.html
SOURCE Danaher Corporation